Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD

References

• Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370:741–750.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010; 170:560–565.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans, V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095–2128.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543–1554.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. J Am Med Assoc 1994; 272:1497–1505.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993; 52:521–527.
   PubMed Web of Science ®Google Scholar
• Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax 2006; 61:854–862.
   PubMed Web of Science ®Google Scholar
• Kwong JC, Ratnasingham S, Campitelli MA, Daneman M, Deeks SL, Manuel DJ, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One 2012; 7:e44103.
   PubMed Web of Science ®Google Scholar
• Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, et al. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. Arch Intern Med 2011; 171:914–920.
   PubMed Web of Science ®Google Scholar
• Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG. Inhaled anticholinergic drugs and risk of acute urinary retention. BJU Int 2011; 107:1265–1272.
   PubMed Web of Science ®Google Scholar
• Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacist Association, 2013.
   Google Scholar
• Hux JE, Naylor CD, Fielding DA. The Ontario Drug Benefit Program Copayment: Its Impact on Access for Ontario Seniors and Charges to the Program. 1997. Toronto, Ontario, Canada, Institute for Clinical Evaluative Sciences in Ontario.
   Google Scholar
• Institute for Clinical Evaluative Sciences. Institute for Clinical Evaluative Sciences 2015 Available from: URL: www.ices.on.ca.
   Google Scholar
• Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physician diagnosed COPD in health administrative databases. Int J Chron Obstruct Pulmon Dis 2009; 6:388–394.
   Web of Science ®Google Scholar
• Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease (COPD). Lancet 2011; 378:991–996.
   PubMed Web of Science ®Google Scholar
• Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, et al. Comparison of inhaled long-acting beta-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Ann Intern Med 2011; 154:583–592.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, et al. Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008; 15 Suppl A:1A–8A.
   PubMed Web of Science ®Google Scholar
• Finkelstein MM. Ecologic proxies for household income: how well do they work for the analysis of health and health care utilization? Canadian journal of public health 2004; 95:90–94.
   PubMed Web of Science ®Google Scholar
• PCCF+ Version 4D User's Guide (Geocodes/PCCF ). Automated Geographic Coding Based on the Statistics Canada Postal Code Conversion Files, Including Postal Codes to December 2003. Ottawa: Statistics Canada, 2004.
   Google Scholar
• The Johns Hopkins University ACG Case-Mix System. Version 8.0. Baltimore, U.S.A.: The John Hopkins University, 2006.
   Google Scholar
• Austin PC, Stanbrook MB, Anderson GM, Newman A, Gershon AS. Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease. Ann Epidemiol 2012; 22:881–887.
   PubMed Web of Science ®Google Scholar
• Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006; 46:1481–1486.
   PubMed Web of Science ®Google Scholar
• D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265–2281.
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46:399–424.
   PubMed Web of Science ®Google Scholar
• Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011; 10:150–161.
   PubMed Web of Science ®Google Scholar
• Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007; 26:734–753.
   PubMed Web of Science ®Google Scholar
• Austin PC. A tutorial on the use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 2013.
   Web of Science ®Google Scholar
• Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation 2016; 133:601–609.
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170:244–256.
   PubMed Web of Science ®Google Scholar
• Gastwirth JL, Krieger AM, Rosenbaum PR. Dual and simultaneous sensitivity analysis for matched pairs. Biometrika 1998; 85:907–920.
   Web of Science ®Google Scholar
• Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician 2010; 81:617–622.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1:73–83.
   PubMed Web of Science ®Google Scholar